Three-dimensional common-feature hypotheses for octopamine agonist 2-(arylimino)imidazolidines

被引:16
作者
Hirashima, A
Morimoto, M
Kuwano, E
Taniguchi, E
Eto, M
机构
[1] Kyushu Univ, Grad Sch, Fac Agr, Dept Appl Genet & Pest Management,Higashi Ku, Fukuoka 8128581, Japan
[2] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan
[3] Kyushu Tokai Univ, Sch Agr, Kumamoto 8691404, Japan
[4] Kyushu Womens Univ, Yahatanishi Ku, Fukuoka 8078586, Japan
关键词
D O I
10.1016/S0968-0896(01)00247-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three-dimensional pharmacophore hypotheses were built from a set of 10 octopamine (OA) agonist 2-(Arylimino)imidazolidines (AIIs), 2-(Arylimino)thiazolidines (AITs) and 2-(Arylimino)oxazolidines (AIOs). Among the 10 common-featured models generated by program Catalyst/HipHop, a hypothesis including a ring aromatic (RA), a positive ionizable (PI) and three hydrophobic aliphatic (HpAl) features was considered to be important in evaluating the OA-agonist activity. Active OA agonist 2,6-Et-2 All mapped well onto all the RA, PI and HpAl features of the hypothesis. On the other hand, less active compounds were shown to be difficult to achieve the energetically favorable conformation which is found in the active molecules in order to fit the 3-D common-feature pharmacophore models. Taken together, 2,6-Et-2-Ph and foramidine structures are important as OA agonists. The present studies on OA agonists demonstrate that a RA, a PI and three HpAl sites located on the molecule seem to be essential for OA-agonist activity. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:117 / 123
页数:7
相关论文
共 17 条
[1]   Identification of common functional configurations among molecules [J].
Barnum, D ;
Greene, J ;
Smellie, A ;
Sprague, P .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1996, 36 (03) :563-571
[2]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[3]  
GOLENDER VE, 1993, 3D QSAR DRUG DESIGN, P137
[4]   CHEMICAL FUNCTION QUERIES FOR 3D DATABASE SEARCH [J].
GREENE, J ;
KAHN, S ;
SAVOJ, H ;
SPRAGUE, P ;
TEIG, S .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1994, 34 (06) :1297-1308
[5]   RHO-SIGMA-PI ANALYSIS . METHOD FOR CORRELATION OF BIOLOGICAL ACTIVITY + CHEMICAL STRUCTURE [J].
HANSCH, C ;
FUJITA, T .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (08) :1616-&
[6]   Three-dimensional pharmacophore hypotheses for the locust neuronal octopamine receptor (OAR3). Part 2: Agonists [J].
Hirashima, A ;
Pan, CP ;
Kuwano, E ;
Taniguchi, E ;
Eto, M .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (07) :1437-1443
[7]   ACTION OF 2-ARYLIMINOTHIAZOLIDINES ON OCTAPAMINE-SENSITIVE ADENYLATE-CYCLASE IN THE AMERICAN COCKROACH NERVE CORD AND ON THE 2-SPOTTED SPIDER-MITE TETRANYCHUS-URTICAE KOCH [J].
HIRASHIMA, A ;
YOSHII, Y ;
ETO, M .
PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 1992, 44 (02) :101-107
[8]   Three-dimensional pharmacophore hypotheses of octopamine receptor responsible for the inhibition of sex-pheromone production in Helicoverpa armigera [J].
Hirashima, A ;
Rafaeli, A ;
Gileadi, C ;
Kuwano, E .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1999, 17 (01) :43-+
[9]   SYNTHESIS AND OCTOPAMINERGIC-AGONIST ACTIVITY OF 2-(ARYLIMINO)THIAZOLIDINES, 2-(ARALKYLAMINO)-2-THIAZOLINES, AND RELATED-COMPOUNDS [J].
HIRASHIMA, A ;
TARUI, H ;
ETO, M .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1994, 58 (07) :1206-1209
[10]  
Hirashima A, 1996, J PESTIC SCI, V21, P419